UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Life Technologies - aTyr Pharma (NASDAQ:LIFE)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

In a report published Friday, Jefferies & Company reiterated its Buy rating on Life Technologies (NASDAQ: LIFE), and raised its price target from $55.00 to $58.00.Jefferies noted, “LIFE's 3Q12 EPS of $0.92 was $0.03 ahead of consensus on stronger profitability trends and a lower share count (+$0.01). We are raising our 2012 and 2013 EPS forecasts to $3.97 (from $3.90) and $4.20 (from $4.15), respectively, to account for the 3Q12 upside and the accretive effects of recent share repurchase activities. Our PT moves to $58 (from $55).”Life Technologies closed on Thursday at $50.27.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!